Kolon Life Science Inc
KOSDAQ:102940
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kolon Life Science Inc
KOSDAQ:102940
|
KR |
|
A
|
Apollo Global Capital Inc
XPHS:APL
|
PH |
|
T
|
Timeless Software Ltd
HKEX:8028
|
HK |
|
Bandhan Bank Ltd
NSE:BANDHANBNK
|
IN |
|
C
|
Carpenter Tan Holdings Ltd
HKEX:837
|
CN |
|
K
|
K Seng Seng Corporation Bhd
KLSE:KSSC
|
MY |
|
Y
|
Yulho Co Ltd
KOSDAQ:072770
|
KR |
|
Q
|
Qinhuangdao Tianqin Equipment Manufacturing Co Ltd
SZSE:300922
|
CN |
|
S
|
Simpar SA
BOVESPA:SIMH3
|
BR |
|
H
|
Hangzhou EZVIZ Network Co Ltd
SSE:688475
|
CN |
|
Vontron Technology Co Ltd
SZSE:000920
|
CN |
|
Technos SA
BOVESPA:TECN3
|
BR |
|
MedMira Inc
XTSX:MIR
|
CA |
|
C
|
Cloud Village Inc
HKEX:9899
|
CN |
|
BKW AG
LSE:0QQ0
|
CH |
|
L
|
Lampsa Hellenic Hotels SA
ATHEX:LAMPS
|
GR |
|
L
|
Lianlian DigiTech Co Ltd
HKEX:2598
|
CN |
|
J
|
JIANGSU LOPAL TECH Co Ltd
SSE:603906
|
CN |
Kolon Life Science Inc
KOLON Life Science, Inc. engages in the manufacture and sale of pharmaceuticals and environment materials. The company is headquartered in Seoul, Seoul and currently employs 451 full-time employees. The company went IPO on 2009-04-07. The firm operates its business under two segments. The Chemical Business segment produces and sells raw drug products, which are the raw materials of new drugs and generic drugs, antibacterial agents that suppress bacterial growth, water treatment agents for environmental purification, and functional material products for cosmetics. The Bio Business segment manufactures and sells bio new medicines based on cell gene therapy products.
KOLON Life Science, Inc. engages in the manufacture and sale of pharmaceuticals and environment materials. The company is headquartered in Seoul, Seoul and currently employs 451 full-time employees. The company went IPO on 2009-04-07. The firm operates its business under two segments. The Chemical Business segment produces and sells raw drug products, which are the raw materials of new drugs and generic drugs, antibacterial agents that suppress bacterial growth, water treatment agents for environmental purification, and functional material products for cosmetics. The Bio Business segment manufactures and sells bio new medicines based on cell gene therapy products.
